Phathom Pharmaceuticals (PHAT) Share-based Compensation Growth (3y) (2022 - 2026)
Phathom Pharmaceuticals (PHAT) Share-based Compensation Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -50.27% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 945.22 Mn | 761.46 Mn | 46.31 Mn | 41.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.81% |
| Dec 31, 2025 | -5.54% |
| Sep 30, 2025 | 16.92% |
| Jun 30, 2025 | 12.02% |
| Mar 31, 2025 | -1.38% |
| Dec 31, 2024 | 15.52% |
| Sep 30, 2024 | 8.44% |
| Jun 30, 2024 | 12.91% |
| Mar 31, 2024 | 13.79% |
| Dec 31, 2023 | 117.81% |
| Sep 30, 2023 | 43.68% |
| Jun 30, 2023 | 106.14% |
| Mar 31, 2023 | 132.19% |
| Dec 31, 2022 | 169.53% |
| Sep 30, 2022 | 439.69% |
| Jun 30, 2022 | 363.77% |